Peer-reviewedCC BY-NC-NDTranslational pediatrics
How should hydrocortisone be used for bronchopulmonary dysplasia in preterm infants?
- 1Department of Neonatal Medicine, Osaka Women's and Children's Hospital, Osaka, Japan.
Related
- Early prophylactic low-dose hydrocortisone for bronchopulmonary dysplasia prevention in extremely preterm infants: a systematic review and meta-analysis
- Safety risk identification and family empowerment needs in home oxygen therapy for preterm infants with bronchopulmonary dysplasia: a qualitative study
- Diuretics for Management of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension in Preterm Infants-A Systematic Review.
- Effects of Neurally Adjusted Ventilatory Assist on Lung Ultrasound Aeration and Diaphragmatic Function in Extremely Preterm Infants With Evolving or Established Bronchopulmonary Dysplasia.
- Early Tracheal and Salivary miRNAs in Extremely Preterm Infants Predict Bronchopulmonary Dysplasia-Related Pulmonary Hypertension.
BibTeX
@article{sakaguchi2026should,
title = {{How should hydrocortisone be used for bronchopulmonary dysplasia in preterm infants?}},
author = {Daisuke Sakaguchi and Katsuya Hirata},
journal = {Translational pediatrics},
year = {2026},
month = oct,
doi = {10.21037/tp-2026-0765},
url = {https://europepmc.org/article/MED/42996749},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - How should hydrocortisone be used for bronchopulmonary dysplasia in preterm infants?
AU - Daisuke Sakaguchi
AU - Katsuya Hirata
PY - 2026
DA - 2026/10/20
JO - Translational pediatrics
DO - 10.21037/tp-2026-0765
UR - https://europepmc.org/article/MED/42996749
SN - 2224-4336
SN - 2224-4344
ER -